A combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor, according to Moffitt Cancer Center research. Peter A...
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report. The...
Initial vaccinations for HPV for women aged younger than 14 years significantly reduced the incidence of condylomata acuminata, according to study results. However, out-of-pocket vaccination costs influenced vaccine...
Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The University of Texas MD...
For roughly 20 years, scientists have been working to engineer a virus that will attack cancer. The basic idea is sound, and every few years there have been some promising-looking results, with tumors shrinking...
A research team from the University of Cincinnati Cancer Institute recently developed a new oral vaccine that produces a novel immune system defense against cancer cells, particularly against the recurrence of breast...
Cervical cancer is one of the most preventable of all cancers. Screening can detect cervical cell changes before they become cancerous lesions and treatment has excellent survival outcomes. The commercial launch of a...
Most people think of the flu when the word “vaccine” comes up in conversation, but several vaccines also exist to help prevent cancers. Not only that numerous researchers are also working to harness the...